Anthony C.
- Country
- France
- Department
- Emergency Unit
Research Overview
- Phase 3 Randomized, Placebo-Controlled Study on the Efficacy and Safety of Zalunfiban in Pre-Hospital ST-Elevation Myocardial Infarction Patients
- Evaluation of Rivaroxaban Versus Low-Molecular-Weight Heparin for Thromboembolism Prevention in High-Risk Patients with Lower Limb Trauma Requiring Immobilization
- Evaluation of Prednisone and Antihistamine Combination Versus Antihistamine Monotherapy in Acute Urticaria Management in Emergency Department Settings
Data & Insights
Has run more than one trial at 14 of 76 partner sites.
Specializations
Vascular Medicine
Specialized in the prevention and management of thromboembolic events, particularly in patients with orthopedic immobilization following lower limb trauma. This investigator focuses on developing innovative approaches to anticoagulation therapy.
- Venous Thromboembolism Prevention
- Lower Limb Trauma Management
- Risk Assessment Protocols
Currently exploring comparative therapeutic strategies between novel oral anticoagulants and traditional treatments.
Cardiac Emergency Medicine
Dedicated to advancing treatment protocols for acute myocardial infarction, with particular emphasis on ST-segment elevation myocardial infarction (STEMI). The investigator explores innovative therapeutic interventions in pre-hospital settings.
- Acute Coronary Syndromes
- Pre-hospital STEMI Care
- Emergency Cardiac Interventions
Evaluates novel therapeutic agents for improving outcomes in acute heart attack patients.
Emergency Dermatology
Focuses on optimizing treatment protocols for acute urticaria in emergency settings. The investigator examines the effectiveness of various therapeutic combinations in managing acute allergic reactions.
- Acute Urticaria Management
- Emergency Allergy Treatment
- Antihistamine Therapy
Investigates streamlined treatment approaches for acute allergic conditions in emergency departments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.